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ABSTRACT

INTRODUCTION: Autism spectrum disorder (ASD) is a developmental disorder that is
characterized by difficulty in social interactions, limited range of interests, and repetitive
behaviors. ASD has been shown to negatively affect both ambient vision and the
autonomic nervous system (ANS). The objectives of this thesis were to determine the
efficacy of two novel therapies, visuo-motor training with ambient prism lenses and
repetitive transcranial magnetic stimulation (rTMS), on autonomic balance and EEG
gamma coherence. Heart rate variability (HRV) and skin conductance level (SCL) were
used as indicators of autonomic function. HRV is an excellent indicator of autonomic
balance because it has a low frequency (LF) component, representative of combined
parasympathetic and sympathetic inputs, and a high frequency (HF) component,
representative of parasympathetic only inputs. SCL is controlled solely by sympathetic
inputs and is therefore indicative of sympathetic tone. Gamma coherence refers to the coactivation of different regions of the brain during completion of a task.

DATA COLLECTION: Autonomic measures of heart rate (HR) and SCL were collected
for both the prism lens study and the rTMS study. Patients enrolled in the prism lens
study were fitted with an appropriate pair of lenses and performed daily visuo-motor
exercises for six months. Autonomic data was collected twice: once at the baseline
(before treatment) and again after completing the prism lens training course. Patients
enrolled in the rTMS study underwent 18 weekly sessions of TMS. Autonomic data was
collected during each session. EEG data was collected twice for both the prism lens and
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rTMS study, once before and after the course of therapy. Behavioral checklists such as
the Aberrant Behavior Checklist (ABC) and the Repetitive Behavior Checklist (RBS)
were completed by the subjects’ parents before and after therapy.

DATA PROCESSING AND ANALYSIS: HR and SCL data collected as the patients
watched scenes from The Lion King (prism lens study) or as patients received TMS
(rTMS study) was exported into Microsoft Excel to begin pre-processing. Statistical
analyses were performed using SPSS 14.0 software. HR data was further analyzed using
Kubios HRV software to calculate heart rate variability (HRV) measures. EEG data was
exported into a software program called Brain Electrical Source Analysis (BESA) for
analysis of gamma coherence.

RESULTS: Results from the prism lens study show that average HR among participants
decreased significantly after completion of prism lens therapy. There was also a decrease
in LF power, an increase in the percentage of HF power, a decrease in the ratio of LF to
HF power (cardiac autonomic balance index), and a decrease in SCL. No significant
changes were observed in gamma coherence following prism lens therapy. Results from
the rTMS study show changes in several measures that reached significance: increased
RR interval (time lapse between successive heartbeats), increased SDNN (standard
deviation of RR interval), increased HF component of HRV, decreased LF/HF ratio, and
decreased SCL. In addition, there was increased gamma coherence between frontaltemporal regions and frontal-parietal regions following TMS therapy.
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CONCLUSIONS: ASD has been shown to present symptoms of disrupted autonomic
balance resulting from excess activity of the sympathetic branch and suppressed
parasympathetic activity. In this thesis, autonomic balance, as indicated by HRV and
SCL, was used as a measure of the effectiveness of two novel therapies for the treatment
of ASD: prism lenses and rTMS. Both therapies resulted in an improvement of autonomic
balance through the activation of the parasympathetic branch and/or by reducing activity
of the sympathetic branch. Prism lens therapy did not improve gamma coherence;
however, TMS therapy was shown to increase gamma coherence between frontal-parietal
and frontal-temporal regions during processing target stimuli.
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I. INTRODUCTION

A. Prevalence of Autism and Clinical Significance
ASD is characterized by difficulty in social interactions, lack of communication,
and a restricted range of interests. ASD can be detected very early, even as young as 3
months of age. It was estimated by the Centers for Disease Control and Prevention
(CDC) that in 2010 ASD affected approximately 1 in 68 children (Baio, 2014).
According to several recent theories sensory processing abnormalities may play an
important role in impairments of perception, cognition, and behavior in individuals with
ASD. Among these sensory abnormalities visual distortion may contribute to such typical
symptoms of ASD as relying on peripheral vision, strabismus, and manifestation of
stereotypic behaviors (Kaplan, 2006; Dombroski et al., 2014).
It is also thought that ASD can manifest itself in abnormalities of the autonomic
nervous system (ANS). The ANS is the non-voluntary part of the nervous system. It
consists of two branches that work as antagonists to control organ function. In most cases
the sympathetic branch acts to stimulate organ function. During times of stress the
sympathetic system increases heart rate, skin conductance, blood pressure, and
respiration, but also significantly decreasing activities not essential to immediate survival,
such as digestion. Therefore, the sympathetic branch plays an important role in the “fight
or flight” response. The parasympathetic branch typically acts as an inhibitor and
operates when conditions are normal and the individual is at ease. In individuals without
ASD a continuous balance exists between these two branches. However, in individuals
with ASD there may be inappropriate activation of the sympathetic system even when
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there are no stress inducers, leading to decreased autonomic control and a general state of
anxiety. This autonomic imbalance may result in symptoms such as lack of blood
pressure and temperature regulation, increased heart rate and skin conductance, and
digestive issues.

B. The Autonomic Nervous System: HRV and SCL
Heart rate variability (HRV) is defined as the variation in the time interval
between heartbeats, and is an important indicator of autonomic function (Berntson et al.,
1997). Numerous studies have shown there are significant differences in HRV between
individuals with anxiety disorders and those without, suggesting that abnormalities in the
ANS play an important role in such disorders. In a study by Thayer et al. the researchers
compared responses of three groups on patients to laboratory stressors: panickers, blood
phobics, and nonanxious controls. Results demonstrated that panickers had the highest
rates combined with the lowest HRV, while controls showed the greatest HRV. Blood
phobics had higher level of vagal heart rate control than panickers, but less than the
nonanxious controls (Friedman & Thayer, 1998).
Currently, HRV is used regularly as clinical indicator for the risk of myocardial
infarction and as a marker of diabetic neuropathy. However, as the study by Friedman
and Thayer described above suggests, HRV is becoming increasingly popular as a
measurement tool for ANS function and overall health. HRV includes many indices that
are described below (Kleiger et al., 2005):
Time-domain measures of HRV include:
1. Mean RR: Average of the R-R intervals for the entire session
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2. STD RR (SDNN): Standard deviation of all normal to normal R-R (NN)
intervals
3. Mean HR: Average of heart rate for the entire sessions
4. STDHR: Standard deviation of heart rate
5. RMSSD: Square root of the mean of the squares of successive NN interval
differences (or the average change in interval between beats)
6. NN50: The number of NN intervals differing by >50 ms from the preceding
interval
7. pNN50: The percentage of intervals >50 ms different from preceding interval

Frequency-Domain Results (Fast Fourier Transform) of HRV include:
1. High frequency (HF) component of HRV (0.15 – 0.40 Hz) is representative of
parasympathetic cardiac control
2. Low frequency (LF) component of HRV (0.04 – 0.15 Hz) is an index of
combined parasympathetic and sympathetic control
3. LF/HF ratio compares the powers of the LF and HF frequency bands and is
considered a cardiac autonomic balance index

The HF component of HRV is often referred to as respiratory sinus arrhythmia
(RSA) and is assumed to be the non-invasive index of parasympathetic influences on the
heart (Sohn et al., 2001). As the HF component is indicative of parasympathetic function,
it is thus also associated with vagal tone. Several studies have supported the hypothesis
that increased vagal tone is associated with better social functioning. Studies involving
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infants found a positive correlation between vagal tone and emotional reactivity to
positive, novel, and negative situations (Fox, 1989; Calkins, 1997). Infants with high
vagal tone were more sociable (Fox, 1989) and better adjusted to new social
environments (Fox and Field, 1989). Another study on HRV found that preschool
children with inhibited temperament, a potential precursor of anxiety in school-age
children, had reduced HRV measures. This finding suggests that reduced parasympathetic
activity may contribute to the association between elevated HR and anxiety in school-age
children (Kagan et. al, 1987).
The LF component of HRV has been linked to sympathetic nervous system
activity and sympathovagal balance by numerous studies (Malliani et al., 1994; Pagani et
al., 1986). However, other studies have shown that the LF variability is rather a reflection
of both sympathetic and vagal influences related to baroreflex mechanisms (Berntson et
al., 1997). It is thought that changes in blood pressure may cause a vagally-mediated
baroreflex response and also changes in LF variability.
Electrodermal activity (EDA) refers to changes in the electrical activity of the
skin, specifically the activity of eccrine sweat glands. EDA is controlled by sympathetic
branch of the ANS (Boucsein, 2012), and is therefore often used as a non-invasive
measure of autonomic function. EDA can be measured in terms of skin conductance
response (SCR) magnitude, non-specific skin conductance response (NS.SCR) frequency,
and skin conductance level (SCL). The magnitude of EDA measures has been shown to
correspond to the strength of an elicited emotion (Boucsein, 1999, 2012). Typically, EDA
increases during stressful situations as the sweat glands become more active. In fact,
EDA is such a reliable measure of stress that it is often used as one of the components of
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the lie detecting apparatus (Gamer, 2011). Several studies have shown that age has an
effect on EDA measures. For example, Plouffe and Stelmack (1984) reported decreased
basal SCL with increased age. A study by Shields (1983) found that young subjects
exhibited a larger magnitude of SCR than adults when presented with sensory stimuli.
EDA measures can also be used to distinguish between different emotions.

C. Autism and the Autonomic Nervous System
Stress plays a major role on the ANS as seen by changes in autonomic variables.
Autistic individuals are vulnerable to high levels of stress due to difficulty with
communication and adapting to new environments (Jansen et al., 2006). For instance, de
Bruin et al. (2007) reported that over 55% of sampled children with ASD met criteria for
at least one anxiety disorder. Similar results were reported in another current study
(McPheeters et al., 2011). Recent years have seen an increasing number of studies
dedicated to understanding the autonomic nervous system abnormalities in ASD. Several
types of autonomic dysfunctions have been reported in autism, including increased basal
sympathetic tone (Hirstein et al., 2001), as well as reduced baseline parasympathetic
activity in association with increased baseline sympathetic tone (Ming et al., 2011;
Porges, 2001). Reduced HRV, specifically the attenuated power of high frequency (HF)
component of the HRV is an indicator of limited psychophysiological flexibility. A
recently published paper by Ming et al. (2012) reported evidence of reduced baseline
parasympathetic activity and increased sympathetic tone in children with ASD. Another
study by Bal et al. (2010) used respiratory sinus arrhythmia (RSA) as a measure of
cardiac vagal tone and compared RSA values between children with and without ASD.
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The study found that children with ASD had significantly lower RSA values and faster
heart rate than those without ASD, which suggests decreased vagal regulation in autism.
The clinical implications of chronic increased sympathetic activity and decreased vagal
tone are poor control of HR and tendency for tachycardia (Berntson et al., 1997, 2008;
Coronoa et al., 1998; Friedman & Thayer, 1998).
Studies dedicated to the relationship between ASD and the autonomic nervous
system have also found manifestations of increased sympathetic activity in EDA
measures. Palkovitz and Weisenfeld (1980) studied SCL in response to auditory stimuli
in children with and without ASD. They did not find differences in electrodermal
reactivity to auditory stimulation compared to controls, but reported that the autistic
group had a higher baseline SCL. In addition, Angus (1970) found that children with
ASD displayed more fluctuations in SCL compared to controls. SCR studies in autistic
children have shown a lack of the normal SCR habituation to the same stimulus over time
(Toichi & Kamio, 2003). It has also been reported that children with autism had blunted
autonomic arousal to visual or auditory social stimuli (Hirstein et al., 2001). SCL is
controlled solely by the sympathetic inputs (Boucsein 2012; Williams et el. 2004);
therefore, the above findings are indications of high sympathetic tone and low selectivity
of ANS responses in autism.

D. Gamma Coherence in Autism
EEG oscillations can be separated into several different frequency bands: delta
(0.5 – 4 Hz), theta (4 – 8 Hz), alpha (8 – 13 Hz), beta (13 – 30 Hz), and gamma (30 – 80
Hz). The frequency band of most interest in this thesis is gamma, specifically from 30 –
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45 Hz. Gamma frequencies in particular have been linked to sensory processing, working
memory, attention, and other cognitive domains (Jensen et al. 2007; Ward 2003). Two
gamma oscillations are typically observed after a stimulus. The first, evoked gamma,
appears within the first 200 ms post-stimulus. The second, induced gamma, typically
occurs within the region of 300 – 600 ms post-stimulus. Evoked gamma tends to be fixed
in its onset, or latency, and is therefore associated with sensory processing and does not
vary from task to task. Conversely, induced gamma oscillations vary in latency and are
thought to be involved in higher cognitive processes, such as pattern recognition or
memory (Tallon-Baudry, 2003). Coherence is a measurement, varying between zero and
one, of correlating gamma activity between two regions of the brain. Coherence suggests
how well the different regions are working together to complete a common task. Previous
studies have found that gamma coherence abnormalities are present in ASD, including
deficiencies in long-distance connectivity and increased connectivity between local
regions (Casanova et al., 2013)

E. Novel Therapies for the Treatment of Autism
This thesis describes two novel therapies, visuo-motor training using prism lenses
and repetitive transcranial magnetic stimulation (rTMS), and their effects on autonomic
balance and gamma oscillations coherence. These two studies were carried out
separately. The efficacy of both treatment methods was determined by measuring
autonomic variables (HRV and SCL) and gamma coherence.
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II. CASE I: PRISM LENS THERAPY

A. Background Information
The sense of vision is used to gather information about our surroundings, read
directions, recognize familiar faces, and numerous other activities. Vision can be
classified into two main types. The first, focal, is conscious and allows us to see objects
in high-resolution color. At the doctor’s office it is focal vision that is tested and given a
score, sometimes resulting in the prescription of corrective lenses for near- or
farsightedness. The other type of vision is known as ambient vision, which is largely nonconscious and is used in spatial orientation and depth perception. Unlike focal vision,
which is restricted to two degrees of visual field, ambient vision involves the entire visual
field and integrates with other sensory systems to determine one’s position in space.
Deficits in this ambient vision system could clearly cause for confusion, disorientation,
and stress. Such deficits have been linked to autism spectrum disorder (ASD), attention
deficit hyperactivity disorder (ADHD), and other developmental disorders by previous
studies. In fact, some of the stereotypical behaviors of ASD are actually the individual’s
attempts to determine his or her orientation in space (Kaplan, 2006; Dombroski et al.,
2014). Prism lenses have the ability to improve ambient vision, thus reducing the stress in
trying to decipher one’s environment. In a prior study by Kaplan et al. (1998) the
behavior, attention, and orientation of two groups of autistic individuals were evaluated
over a period of 4 months. One group wore prism lenses and the other wore placebo
lenses. At the 1.5 month mark, individuals in the prism lens group showed a decrease in
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behavior problems compared to the placebo group. A slight loss of these benefits was
observed at the 3 and 4 month mark.

B. Protocols and Data Collection
1. Subject Demographics
Fourteen out of 24 children enrolled in the study completed the whole course of
prism lenses treatment and visuo-motor training, along with baseline and post-treatment
assessments. Mean age of participants was 13.1 years (SD=3.37 yrs), range varied within
8-19 years, and 4 of them were girls. All participants’ ASD diagnosis was made
according to the DSM-IV-TR (APA, 2000) and further ascertained with the Autism
Diagnostic Interview – Revised (ADI-R) (Le Couteur et al., 2003). They also had a
medical evaluation by a developmental pediatrician. All subjects had normal hearing
based on past hearing screens. All autistic participants were high-functioning persons
with full scale IQ > 80 assessed using the Wechsler Intelligence Scale for Children
(WISC-IV; Wechsler, 2004). Four out of 14 participants had a diagnosis of Asperger’s
Disorder. Study participants were recruited through advertisement posted at local autism
advocacy organizations (e.g., Louisville Chapter of FEAT) and some were recruited from
existing pool of children with ASD seeking treatment.
2. Determining each subject’s prism lens prescription
Dr. Melvin Kaplan from the Center for Visual Management (Terrytown, NY)
visited the University of Louisville twice and on-site observed each patient’s head tilt,
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body posture, facial expressions, and breathing during visual pursuits, ball catching, and
watching TV to determine which base direction of ambient lenses should be prescribed
for each patient (Figures 1 and 2). Prism lenses were manufactured at the optic center in
the state of New York following Dr. Kaplan’s prescription to each participant.

FIGURE 1- Dr. Kaplan conducting evaluations to prescribe prism lenses

3. Daily vision exercises
At the beginning of each month, each study participant along with prescribed
lenses received a packet of visuo-motor exercises program that were to be done for Week
1, Week 2, Week 3 and Week 4. Each week’s exercises were designed to build
neurosensory and neuromuscular skills from one week to the next. A description of the
materials, lenses, setup, procedure, observations and time expected to be spent on each
exercise were all included in the instructions. The prescription prism lenses, the
dysruptive lenses and the red/green lenses were all provided by the Center for Visual
Management. The materials needed involved a combination of household items and a few
items that were relatively inexpensive to buy or build on your own, such as a balance
board and a chalk board. At the end of each month, patients came into the lab at the
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University of Louisville for a post-assessment evaluation and video recording of selected
procedures chosen by the Center for Visual Management. The video recordings were
mailed to the Center for Visual Management for oversight in determining each patient’s
progress throughout the study.
Month 1: The purpose behind the exercises assigned for month 1 was to disrupt
and reintegrate the visual system. Observational changes could be seen in the patient’s
stress level, ease or difficulty in reorganizing visual perception and balance to the base
direction, level of comfort or discomfort in completing the exercise, sustained visual
attention, awareness of double vision, visual tracking, hand-eye coordination, smooth or
uncoordinated movements, visual convergence, proper posture, and improved perception
of distance and speed. In addition to the prescription prism lenses, the disruptive lenses
and/or the red/green lenses, other equipment used in these exercises included a balance
board, a trampoline and a yoga mat.
Month 2: The visuo-motor exercises assigned for the second month utilized a
visual-vestibular technique to enhance body schema and self-awareness, develop visualvestibular integration, coordinate balance and visual attention to self, and engage
binocular fusion. Additionally, patients practiced sustaining visual feedback to a focal
target, while increasing ambient awareness and reorganizing current visual perceptual
patterns and visual fields which may have been previously compressed prior to wearing
prism lenses and visuo-motor therapy. Additional equipment used in some of these
exercises included a full length mirror, a “Star” chart, and a chalkboard.
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Month 3: The purpose of this month’s exercises was to engage bilateral
movements and visual-auditory integration as well as increase visual attention and eye
movement skills including tracking and coordination. Other objectives included the
introduction of fixation jumps to expand the visual eye field while incorporating
proprioception of body movement and auditory input to reorganize the patient’s current
visual perceptual patterns as well as promote smooth tracking and breathing skills. New
equipment introduced during this month’s exercises included a metronome, bongos, a
checkerboard, a circle and square chart, and a Hart chart. Figure 2 illustrates one of the
subjects performing these exercises in the lab.

FIGURE 2 – Subject performing visuo-motor exercises
Month 4: During month 4 exercises, patients were asked to read before and after
visuo-motor therapy and trainers were instructed to observe differences in speed, reading
fluency and comprehension as well as changes in breathing and posture, including
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whether or not the patient appeared relaxed or tense. The primary goal of this month’s
exercises was to integrate two visual tracts, both focal and ambient vision while also
creating depth perception, increasing smooth eye movements, and increasing visual
attention and tracking ability. Additional equipment during this month’s exercises
included a pie tin, a slinky on a dowel, two matchbox cars or tennis balls, and bubble
blowing solution with a wand.
Month 5: A constant theme throughout visuo-motor therapy is to increase visual
attention, eye movements and tracking ability. For this month’s exercises, several
previously learned procedures were repeated, but now combined with other procedures to
create depth perception, increase smooth eye movements, develop visual-vestibular
integration and increase visual processing ability. Much of the same equipment was
reused during this month’s exercises; however, a walking rail was added to incorporate
balance and depth perception with an exercise that was previously done sitting or
standing in a stationary position.
Month 6: The final month’s exercises for this study highlighted the fusion of
vision and auditory integration with controlled breathing, increased proprioceptive input,
visual attention, convergence skills and depth perception. This study concluded with the
integration of visual-verbal sequences in which the patient was directed to name items
such as animals or fruits in alphabetical order or simply count or recite the alphabet while
bunting the ball. The ability to provide a correct verbal response while visually attending
to and physically making contact with the ball is the direct result of cortical
reorganization of the vision system.
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4. Psychophysiological reactivity tests
Data was collected while the patients watched emotionally arousing video
excerpts taken from the classic Disney film The Lion King (Figure 3). Each episode (high
and low emotional context block) was 2 minutes long, while a total of 4 episodes were
used, thus making the period of watching video up to 10 minutes. The order of movie
episodes was counterbalanced across all subjects. HR and SCL was monitored and
collected during the session. Physiological activity was recorded using C-2 J&J
Engineering Inc (Poulsbo, WA) real-time physiological monitor with USE-2 Physiodata
software while watching The Lion King episodes with prism lenses. The test was
conducted twice, at the baseline (before treatment) and after completion of the prism
lenses treatment course.

FIGURE 3 – Low Emotional (Left) and High Emotional (Right) scenes selected
from the classic Disney film, The Lion King.

5. Behavioral Checklists
Participants were also evaluated using the following questionnaires: Aberrant
Behavior Checklist (ABC) (Aman & Singh, 1994) and Repetitive Behavior Scale (RBS)
(Bodfish et al., 1999).
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6. Posner Spatial Attention Task
EEG data, to be used for analysis of gamma coherence, was collected before and
after the six months of prism lens therapy while subjects completed a cued Posner spatial
attention task. In this task, subjects pressed a button to indicate on which side of the
screen the stimulus “X” appeared. Before each stimulus, subjects were presented with a
pre-cue red square. In the congruent condition the “X” appears in the red square, while in
the incongruent condition the “X” appears in the opposite square. This task consisted of
two blocks each 10 minutes long. In one block the stimuli are oriented horizontally, as in
the left side of Figure 4; in the other block the stimuli appear in the corners (diagonal), as
shown in the right side of Figure 4.

FIGURE 4 – Cued Posner Spatial Attention Task

C. Data Analysis

1. Heart Rate Variability
Analysis of HRV began with a recording (usually 5-10 minutes) of an individual’s
electrocardiogram (EKG). The USE-2 Physiodata software program then derived HR
from the EKG signal by detection of adjacent QRS complexes. After export of the data,
15

applying a simple conversion to HR yielded the time between heartbeats, known as the
RR interval. The RR interval was then opened in Kubios HRV software (Helsinki,
Finland) for artifact removal and calculation of HRV measures. Figure 5 (top) shows the
RR interval graphed over the entire recording session. The two noticeable peaks are
artifacts, possibly due to subject movement, that can distort the results of HRV measure
calculation. Figure 5 (bottom) shows the same RR data with the artifacts removed. Only
the highlighted yellow region was used in calculation of HRV measures for this particular
session.

FIGURE 5 – Representation of artifact removal in Kubios HRV
Kubios HRV uses the selected region of RR data to calculate measures such as
mean RR, SDNN, mean HR, STDHR, RMSSD, NN50, and pNN50. Calculations of a
few of these time-domain measures are shown below in Equations 1-3. Table 1 shows
example time-domain results for one subject.
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Equations 1-3: Calculations for time-domain HRV measures

TABLE I
EXAMPLE TIME-DOMAIN HRV RESULTS
Measure
Mean RR
SDNN
Mean HR
STDHR

Units
ms
ms
bpm
bpm

Value
691.2
112.6
88.64
11.76

RMSSD
NN50
pNN50

ms2
count
%

129.9
124
29.9

To obtain frequency-domain results, a power spectrum density (PSD) was
calculated using a Fast Fourier Transform (FFT). The frequency-domain measures were
then extracted from the PSD. The absolute, relative, and peak powers were reported for
each frequency band. Integration of the spectrum over the respective regions allowed for
calculation of the absolute power of each frequency band (Tarvainen & Niskanen, 2012).
Another option for derivation of the frequency-domain measures is to use autoregressive
(AR) modeling. These methods, FFT and AR, are the two most commonly used for
spectral analysis. FFT spectral analysis includes all data in the series, whereas the AR
17

method uses a model-fitting approach to identify the more significant peaks from which
the final spectrum is derived (Porges & Bohrer, 1990; Berntson et al., 1997). Data that
does not fit the model is considered to be noise and is either partially or completely
removed. In addition, the AR modeling technique requires an estimation of the model
order, for minimization of prediction error, prior to spectral analysis. There are several
different criteria for the estimation of model order, and many theories about which
combination of criteria yields the most accurate model order. (Boardman et al., 2002).
The AR technique is recommended when the number of data points is low, since the
frequency resolution of the AR-derived spectrum is not as dependent as the FFT method
on the length of the recording (Parati et al., 1995). The number of data points in this
experiment was large, therefore, the FFT method was selected as optimal. Figure 6 shows
an example of a PSD derived using the FFT method, and Table 2 is an example of the
extracted frequency-domain measures for the VLF, LF, and HF frequency bands.

FIGURE 6 - Example PSD derived using the Fast Fourier Transform method
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TABLE II
EXAMPLE FREQUENCY-DOMAIN HRV RESULTS

2. Skin Conductance
Skin conductance data was exported into Microsoft Excel. All statistical analysis
(t-test and regression) was done using SPSS Statistics software.
3. Gamma Coherence
Raw EEG data was recorded as a time signal using EEG electrodes and opened in
Brain Electrical Source Analysis (BESA) for analysis. Figure 7 below depicts an example
of raw EEG data in BESA software.
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FIGURE 7 – Raw EEG opened in BESA software
An issue regarding calculation of coherence is that there two forms of coherence:
scalp and source. The EEG above is referred to as a scalp waveform. Scalp waveforms
can become distorted by overlap between electrode signals on the scalp. Therefore, these
waveforms cannot be used to distinguish between coherence due to propagation (scalp
coherence) and true coherence (source coherence). Montages are user-defined programs
in BESA that allow for computation of coherence between selected regions of the brain,
and based on the montage design, it can also be used to eliminate or reduce the effects of
scalp coherence. The first attempted montage involved 18 different brain regions, shown
below in Figure 8.
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FIGURE 8 – Coherence montage involving 18 channels
The disadvantage of this montage was that it did not take into consideration the
effect of scalp coherence, which is especially pronounced between regions located near
each other, for example, F3 and F4. Many studies in EEG coherence have used the
common reference (Cz) located at the vertex (Mathewson et al., 2012) in calculation of
coherence coefficients. Specifically, source coherence is calculated by averaging the
cross-spectral density of one reference channel with all other channels over trials (BESA
Research Tutorial, 2010). Therefore, the next montage was designed to reference each
electrode to Cz in order to reduce effects of signal propagation between electrodes. The
revised montage is shown below in Figure 9.
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FIGURE 9 – Revised montage with centrally located reference (Cz)
The number of channels to be analyzed was also reduced in the revised montage.
Selection of these channels was based on the following factors. Frontal lobe channels F3
and F4 were included because the frontal lobe is known to regulate problem solving and
emotion. Channels C3 and C4 were included since they are located over the sensory
motor cortex. Lastly, parietal lobe channels P3 and P4 are involved in visual processing.
The new montage was applied to raw EEG data. The resulting source waveform is shown
in Figure 10.
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FIGURE 10 – Source waveform after application of the montage
The next step was to remove artifacts caused by eye blinks or movement from the
waveform. BESA generated a 2-dimensional diagram (Figure 11) organized with
channels on the y-axis and trials on the x-axis, sorted by amplitude of the signal. Certain
artifacts were removed if their amplitude exceeded that defined as the threshold.

FIGURE 11 – Waveform artifact removal in BESA
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Once artifacts have been removed, the source waveform was then used in
calculation of true coherence, which is defined as the oscillatory activity between two
coupled brain regions. Two regions are considered to have coupled oscillatory activity if
the oscillations are correlated in both amplitude and phase. As Figure 12 shows below,
coupled oscillations can have a phase difference but the two regions must have a constant
phase relation.

FIGURE 12 – Phase relationship between two coupled oscillations

Oscillations between two regions are measured over a number of trials, and
several criteria must be met for coherence to be assumed. These criteria are (BESA
Tutorial, 2010):
1. Same frequency in coupled regions within each trial
2. Possible variation of frequency and duration across trials
3. Similar phase difference across trials
4. Similar amplitude fluctuations across trials
Figure 13 shows an example of an analysis between two regions that is accepted
as coherence, and an analysis that does not qualify as coherence.
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FIGURE 13 – Coherent vs. incoherent oscillations
Each oscillation is represented as a time-frequency signal S(f, t) which is the
amplitude of a signal at a given frequency and time post-stimulus. Two time-frequency
signals are used to compute the coherence between the respective brain regions (Equation
4).

(4)
Equation 4: Formula for the calculation of coherence
BESA uses the calculated coherence values to produce coherence maps,
specifically for coherence within the gamma frequency band. These maps are color-coded
(blue = low coherence, red = high coherence) to display coherence of all designated
regions of the brain relative to one region. The region of interest can be interchanged by
selecting a different region. This creates a new set of coherence maps relative to the new
region.
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D. Goals and Expectations
Our hypothesis was that six months of daily visual-motor exercises with prism
lenses would lead to decreased overall HR, increased STDHR, increased HF and/or
decreased LF, decreased SCL, improvement in behavioral checklist scores, and increased
long-distance gamma coherence during the Posner task.

E. Results
Post-treatment, a significant decrease was observed in average HR among the
participants from the baseline 94.6 ± 2.99 beats/min to post-sessions 89.6 ±3.65
beats/min, with paired-sample t-test showing significant change (t=-2.52, p=0.025).
There was a decrease in LF power from 60.2± 2.81 power units to 48.6 ± 3.57 units (t= 2.38, p=0.033) and an increase in the percentage of HF power from 24.8± 2.16 % to 37.6
± 4.61 % (t=2.42, p=0.03). VLF component of HRV (another measure of sympathetic
activity) tended to decrease from 37.8 % down to 29.7%, but the change was not
statistically significant (t=-1.69, p=0.11). Lastly, the LF/HF power ratio decreased from
1.70± 0.22 to 1.06 ± 0.13 (t=-2.52, p=0.025). Figure 14 below shows how the
proportions of HF and LF power changed before and after treatment with prism lenses.
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FIGURE 14 – LF and HF components of HRV pre- and post-treatment

A significant decrease in SCL was observed post-treatment with prism lenses
(Figure 15). The pre-treatment average among subjects was 18.3 µS and post-treatment
average was 7.9 µS (t = -2.824, p = 0.037).
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FIGURE 15 – SCL pre- and post-treatment

In addition, empirical behavioral data outcomes were reported using the Aberrant
Behavior Checklist (ABC) (Figure 16) and Repetitive Behavior Scale (RBS) (Figure 17).
In the ABC, three out of five scaled scores were reduced. In particular, scores tended to
be decreased in Lethargy (t = 2.09, p = 0.058) and Inappropriate Speech (t=2.06, p= 0.06)
while significantly decreased in Hyperactivity (t= 2.39, p = 0.034) compared to baseline
scores. According to the Repetitive Behavior Scale (RBS), three out of six subscale
scores were significantly different. These subscale scores included: Stereotypic Behavior
(t = 3.47, p = 0.01), Compulsive Behavior (t= 3.49, p = 0.01) and overall Total Score (t =
2.70, p = 0.031) compared to baseline scores.
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FIGURE 16 – Outcomes of Aberrant Behavior Checklist questionnaires
showing decreased Hyperactivity score post prism lenses treatment

FIGURE 17 – Outcomes of Repetitive Behavioral Scale questionnaires (RBS)
showing decreased Compulsive Behaviors Score and Total Score post prism lenses
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Lastly, results of the Posner cued spatial attention task show no significant
differences in gamma coherence or latency (time post-stimulus at which coherence was
observed) between pre- and post-prism lens treatment. However, analysis of coherence
between individuals with and without ASD (controls) shows significant differences in
both coherence and latency. Table 3 compares mean coherence coefficient values
between controls and autistic subjects at four different brain region pairings. For
example, the first row in Table 3 describes induced gamma coherence between two
parietal regions (P3 and P4) in the congruent condition, while the second row describes
induced coherence between a frontal and a parietal region (F3 and P3) in the incongruent
condition of the Posner task.
TABLE III
POSNER TASK COHERENCE COEFFICIENT VALUES: CONTROL & ASD
Pair
P3-P4
Induced, Congruent
F3-P3
Induced, Incongruent
P3-P4
Evoked, Incongruent
P3-P4
Induced, Incongruent

Mean Coh: Control

Mean Coh: ASD

F

p-value

.496

.628

4.288

.045

.552

.692

4.586

.039

.586

.798

13.725

.001

.682

.818

6.970

.012

Controls and individuals with ASD also displayed differences in coherence in
response to congruent and incongruent conditions. The results in Table 4 and Figure 18
below indicate that both controls and subjects with ASD had a similar coherence
response to the congruent condition, but that those with ASD had an excessive frontoparietal coherence response (0.692) to the incongruent condition compared to controls
(0.553).
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TABLE IV
INDUCED COHERENCE COEFFICIENT VALUES (F3-P3) OF CONTROL &
ASD GROUPS FOR CONGRUENT AND INCONGRUENT CONDITIONS
Group
Control
ASD

Mean Coh: Congruent
.403
.396

Mean Coh: Incongruent
.553
.692

p-value
.029

FIGURE 18 – Induced gamma coherence responses to congruent and incongruent
conditions for individuals with and without ASD

In addition to differences in coherence, controls and autistic individuals also
displayed differences in latency, the time post-stimulus in milliseconds at which gamma
coherence occurs. Table 5 below shows the differences in latency for three different brain
region pairs. These values suggest that control subjects have a shorter latency period to
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stimuli in the congruent condition, while those with ASD have a shorter latency period
for stimuli in the incongruent condition.
TABLE V
POSNER TASK LATENCY VALUES: CONTROL & ASD
Pair

F4-P4
Evoked, Congruent
F3-F4
Evoked, Incongruent
F4-P4
Evoked, Incongruent

Mean Latency:
Control
(ms)

Mean Latency:
ASD
(ms)

F

p-value

138.4

161.9

4.690

.037

164.8

134.9

6.675

.014

168.9

145.0

5.914

.020

F. Discussion
The analysis steps successfully transformed the raw data, either EKG or EEG,
into a usable form for interpretation of results. Derivation of the RR interval from the
EKG and subsequent artifact removal allowed for calculation of HRV measures in
Kubios HRV software. It was determined that for the large number of data points
collected for each session of autonomic monitoring, FFT was the preferred method of
spectral analysis, as opposed to AR modeling. AR modeling is beneficial for frequencydomain calculations if only a limited number of data points are available. In order to
analyze EEG data, the proper montage was first created in BESA to compute coherence
and reduce effects of propagation between electrodes on the scalp (scalp coherence).
Application of this montage and artifact removal created a waveform suitable for
calculation of source coherence.
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The results of the prism lens study are encouraging in that they support the
hypotheses that ambient prism lenses in combination with therapy vision exercises had
the desired effect on HRV variables and SCL, reflecting improved autonomic balance in
children with ASD. The first result supporting the improved autonomic balance
hypothesis was the decrease in average heart rate. Second, the decrease in LF power and
the increase in HF power were changes in the desired direction toward improved
autonomic balance. This is also seen in the decreased LF/HF power ratio. In addition, the
decrease in SCL suggests a withdrawal of sympathetic tone, since SCL is controlled
solely by sympathetic inputs. These results are in favor with increased parasympathetic
and decreased sympathetic tone, a significant improvement from ANS activity in autism.
Behavioral measures also reflect improvements in hyperactivity and repetitive behaviors.
No significant differences were observed in gamma coherence or latency times in
autistic subjects before and after prism lens therapy. Results did show, however, some
significant differences in both coherence and latency between controls and autistic
subjects. Specifically, those with ASD appeared to show higher coherence in response to
the incongruent condition compared to control subjects. Autistic subjects also displayed
shorter latency periods in response to the incongruent condition. These findings suggest
that those with ASD may have decreased sensitivity in their responses to congruent and
incongruent conditions. While prism lenses were effective in producing desired effects on
HR, HRV, and SCL, the results of the Posner task indicate a different therapy may be
more effective in improving gamma coherence in ASD.
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III. CASE II: TMS THERAPY

A. Background Information
TMS is a non-invasive neuromodulation technique with the potential to increase
fronto-limbic inhibition known to be deficient in ASD. The limbic system is a complex
network of structures central to anxiety and mood regulation (Mayberg, 2003; Sokhadze
et al., 2009). Few studies have investigated the effects of rTMS on the autonomic nervous
system, despite the fact that many frontal cortical areas are involved in autonomic
nervous system control (Czeh et al., 2002; Filippi et al., 2000). The proposed mechanism
of post-TMS effects on autonomic arousal may include improved tonic fronto-limbic
inhibitory influences known to be deficient in autism (Loveland et al., 2008). The aim of
this research project was to observe the effects of 18 sessions of rTMS in improving
autonomic functions in children with ASD.
The organization of neurons in the cortex is based on cellular minicolumns.
Previous research suggests that there is a greater number of minicolumns in the cortex of
an individual with ASD, accompanied by increased neuronal density and reduced
neuropil space (periphery of the minicolumn) (Casanova et al., 2002; Casanova et al.,
2006). This lack of neuropil space is thought to reduce inhibitory effects, leading to
dysfunction of sensory processing and overexcitement of the neurons. TMS applied to the
DLPFC can improve excitability/inhibition of neural circuits, specifically by increasing
cortical inhibitory neurons (Sokhadze et al., 2010). There are two forms of TMS: slow
and fast. “Slow” TMS falls in the range of 0.3 – 1 Hz, while “fast” TMS is above 1 Hz.
Slow TMS was selected as its effect is to activate inhibitory cells surrounding the
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minicolumns (Sokhadze et al., 2010; Hedeker & Gibbons, 2006; Pascual-Leone et al.,
2000). TMS is generally regarded as a safe procedure. Reported side effects have
included mild, tension-type headache following stimulation and discomfort due to the
sound of the pulses. However, there is a certain risk for inducing seizure (Wasserman et
al., 1996). Therefore, patients with epilepsy or a family history of epilepsy are generally
excluded from receiving TMS.
TMS has already shown to be an effective therapy tool. In a paper by Udupa et al.
(2007) researchers compared rTMS with antidepressant therapy to address the autonomic
imbalance associated with depression. The authors found that rTMS not only produced
antidepressant effects, but also corrected the autonomic imbalance. The researchers used
HRV measures as evidence that rTMS did in fact reduce the sympathetic/parasympathetic
ratio thus improving the sympathovagal balance.
TMS is also becoming increasingly prevalent as a potential therapy for ASD
(Oberman et al., 2013). In previous studies by the Cognitive Neuroscience Lab at the
University of Louisville, slow rTMS was shown to improve both evoked gamma activity
and error processing in individuals with ASD. Baruth et al. (2010) compared evoked
gamma activity in the early stages of visual processing was between individuals with
ASD and those without ASD (controls) using Kanizsa illusory figures. In autistic
individuals, evoked gamma activity was not discriminative of stimulus type, whereas
control subjects displayed early gamma-power differences between target and non-target
stimuli. Individuals with ASD underwent 12 sessions of rTMS and repeated the Kanizsa
test. Results show improvement in discriminatory gamma activity between target and
non-target stimuli, as well as improvement in responses on behavioral questionnaires. In

35

a study by Sokhadze et al., TMS was used to improve error processing in children with
ASD, as measured by event-related potentials (ERP) associated with response to errors,
such as error-related negativity (ERN). Post-TMS results show significant differences in
the response-locked ERP such as ERN, as well as behavioral response monitoring
measures indicative of improved error monitoring and correction function (Sokhadze et
al., 2012).

B. Protocols and Data Collection
1. Subject Demographics
Eighteen children (14 boys and 4 girls) were enrolled in this study (mean age 13.1
years, SD=2.2). Participants were recruited through the University of Louisville
Weisskopf Child Evaluation Center (WCEC). Diagnosis was made according to the
DSM-IV-TR and further ascertained with the Autism Diagnostic Interview – Revised
(ADI-R) (LeCouteur et al., 2003) by Dr. Lonnie Sears, who also did pre- and post-TMS
clinical evaluations. All participants were high-functioning children with ASD and with
full-scale IQs >80 assessed using the Wechsler Intelligence Scale for Children, Fourth
Edition (WISC-IV; Wechsler 2004). Two subjects were excluded for bradycardia. For
another two subjects the data could not be retrieved due to high number of artifacts.
Therefore, data was reported for 14 children.

2. TMS Specifications
The TMS instrument used was the Magstim Model 220 (Magstim Corp., Wales,
UK) with a 70-mm wingspan figure-eight coil. Each session of TMS typically lasts
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between 20 – 30 minutes. Patients were seated in a comfortable chair and fitted with a
swim cap to help indicate the TMS coil position. First, the motor threshold (MT) was
determined for each patient. MT refers to the intensity of the pulse delivered to the motor
cortex necessary to elicit a noticeable motor response. The motor response was monitored
by applying a sensor to the hand muscle opposite the site of stimulation. The output of
the TMS coil was increased by 5% until a 50 µV deflection of electromyogram (EMG)
was seen on the monitor, or until a visible muscle twitch was observed. Once the MT was
established, the coil was moved to the site of stimulation (DLPFC) and the pulse intensity
was adjusted based on the MT. Eighteen sessions of TMS were administered once per
week to patients enrolled in the study. EKG and SCL were recorded during each session
through an EKG-based C-2 J&J monitor. Figure 19 illustrates placement of the TMS
wand over the DLPFC, and Figure 20 details the process of TMS application and data
collection during one session. Figure 21 shows where the EKG, SCL, and EMG sensors
were placed on the subject.
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FIGURE 19 – Administration of rTMS over the DLPFC with physiological monitoring

FIGURE 20 – Schematic of TMS application and autonomic data collection
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FIGURE 21 – Placement of sensors for autonomic data collection

3. Kanizsa Visual Oddball Task
EEG data was collected twice – once before beginning the course of TMS, and
again after completing 18 sessions. Each patient was fitted with an EEG net containing
128 electrodes (Figure 22). While wearing the net, the patient was seated at a computer
and completed a Kanizsa visual oddball task in which he or she was asked to identify
certain images. The task involved pressing a button when a rare (25% probability)
Kanizsa square (target condition) appears as opposed to Kanizsa triangles (non-target
condition) and non-Kanizsa figures. The raw data was exported into the Brain Electrical
Source Assessment (BESA) software package where coherence analysis was carried out.
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As a control, EEG recordings were also taken from a group of patients who did not
participate in TMS (waitlist). Patients on the waitlist were given the opportunity to
receive TMS after the study was completed.

FIGURE 22 – Patient completing Kanizsa task while wearing 128-channel EEG net

4. Behavioral Checklists
Participants were also evaluated using the following questionnaires: Aberrant
Behavior Checklist (ABC) and Repetitive Behavior Scale (RBS).

C. Data Analysis
The same data analysis methods for HRV, SCL, and gamma coherence were used
for the rTMS study as in the prism lens study. However, the montage created in BESA
was altered to replace C3 and C4 with two different channels. Channels C3 and C4 were
appropriate for analysis of EEG data from the Poser spatial attention task because they
are involved in motor function. The Kanizsa visual oddball task is based on recognition
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of visual stimuli. Therefore, channels T7 and T8 were included in the montage for
analysis of data from the Kanizsa task since functions of the temporal lobe include
processing visual stimuli and memory (Eichenbaum et al., 2007).

D. Goals and Expectations
The objectives of the TMS study were to study the effects of 18 sessions on
autonomic measures and gamma coherence in ASD. Expected autonomic outcomes were
decreased overall HR, increased RR interval, increased STDHR, increased SDNN,
increased RMSSD, increased pNN50, increased HF and/or decreased LF, decreased
LF/HF ratio, and decreased SCL. Behavioral checklist scores were expected to improve.
Lastly, TMS therapy was expected to improve gamma coherence between long-distance
regions of the brain.

E. Results
Results of HRV analysis show several measures with significant differences
between pre- and post-TMS therapy. Table 6 below shows the t-test results for RR
interval, SDNN, HF component of HRV, LF/HF ratio, and SCL.
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TABLE VI
T-TEST: PRE/POST TMS THERAPY HRV MEASURES

RR pre-post

ms

Paired Differences
Std.
95% CI
Dev.
Lower Upper
-39.08
53.61
-70.04
-8.13

SDNN pre-post

ms

-39.09

66.78

-77.65

-.54

-2.19

13

.047

HF pre-post

ms2

-1249.3

1556.1

-2147.8

-350.8

-3.00

13

.010

LF/HF pre-post

N/A

.48

.81

.01

.95

2.23

13

.044

SCL pre-post

µS

4.37

5.65

1.11

7.64

2.89

13

.013

Pairs

Units

Mean

t

df

-2.73

13

pvalue
.017

The table above shows that there was a significant increase (p = .017) in the RR
interval from pre- to post-TMS treatment. This result can also be interpreted as a decrease
in HR, since the RR interval is the time between successive heartbeats. The t-test also
reveals significant increases in SDNN and HF power, as well as significant decreases in
the LF/HF ratio and SCL.
Regression analysis was completed to observe trends during the entire 18 session
TMS course. Table 7 shows the results of regression analysis.
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TABLE VII
REGRESSION ANALYSIS: HRV MEASURES OVER 18 SESSIONS OF TMS
R

R2

Reg. Equation

3.524

pvalue
.003

.661

.437

y = 2.696x + 684.57

ms

3.38

.004

.645

.417

y = 2.098x + 52.28

HR

1/min

-2.88

.011

.584

.341

y = -.356x + 89.68

STDHR

1/min

3.10

.007

.613

.376

y = .105x + 6.244

RMSSD

ms

2.15

.047

.473

.224

y = 1.480x + 52.80

NN50

count

3.57

.003

.666

.443

y = 3.598x + 65.15

LF power

ms2

-1.02

.323

.247

.061

y = -15.23x + 1775.4

HF power

ms2

5.12

.000

.788

.621

y = 68.65x + 671.90

LF/HF ratio

N/A

-3.83

.001

.691

.478

y = -.028x + 1.619

SCL

µS

-3.719

.002

.681

.464

y = -.171x + 8.65

Measure

Units

t

RR

ms

SDNN

Regression analysis shows that the trend in each measure was significant for all
analyzed, expect for LF power. Although there was a negative trend for LF power
observed over the 18 sessions of TMS, it did not reach significance. NN50 (count of RR
intervals differing by >50 ms from the preceding interval) does show a significant
positive trend, however, because the length of each physiological recording session was
not uniform, regression analysis results of NN50 are not a reliable reflection of this
measure. pNN50, the percent of RR intervals differing by >50 ms from the preceding
interval, did not show a significant positive trend. Figures 23 – 28 below show the
regression analysis for individual measures.
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FIGURE 23 – Regression trend of RR interval in 18 sessions of rTMS

FIGURE 24 – Regression trend of SDNN in 18 sessions of rTMS
44

FIGURE 25 – Regression trend of HF component of HRV in 18 sessions of rTMS

FIGURE 26 – Regression trend of LF component of HRV in 18 sessions of rTMS
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FIGURE 27 – Regression trend of the LF/HF ratio in 18 sessions of HRV

FIGURE 28 – Regression trend of SCL in 18 sessions of rTMS
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The ABC and RBS behavioral checklists show significant improvements in
several areas. Specifically, ABC scores show improvement in irritability, lethargy, and
hyperactivity post-rTMS, as seen in Figure 29. RBS scores show improvement in
stereotypic behaviors and compulsive behaviors following rTMS treatment, as seen in
Figure 30.

FIGURE 29 – ABC scores changes post-rTMS
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FIGURE 30 – RBS scores changes post-rTMS
Results of gamma analysis from the Kanizsa visual oddball task reveal several
significant differences in coherence between pre- and post-TMS treatment. Table 8 shows
the regions where increased gamma coherence was observed following 18 sessions of
TMS.
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TABLE VIII
KANIZSA TASK COHERENCE COEFFICIENT VALUES: PRE- AND POSTTMS TREATMENT
Pair

F3-T7
Evoked, Target
F3-T7
Induced, Target
F4-P4
Evoked, Target
F3-T7
Induced, Non-target

Mean Coh: Pre-

Mean Coh: Post-

TMS

TMS

F

p-value

.394

.566

6.939

.013

.457

.596

4.605

.040

.156

.278

5.084

.032

.419

.589

6.771

.014

Figure 31 below shows an example of a coherence map for one subject pre- and
post-18 sessions of TMS. These maps show target coherence between the F3 and T7
regions. Blue represents little coherence (close to 0), while red represents more coherence
(close to 1). The light orange color represents and intermediate amount of coherence. As
indicated in Table 8 above, coherence to the target condition between F3 and T7
improved in both the evoked region (100 – 200 ms) and in the induced region (300 – 600
ms). Figure 31 confirms this as there is much more coherence visible in the post-TMS
map compared to the pre-TMS map.
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FIGURE 31 – Pre- (top) and post-TMS (bottom) maps for coherence between F3T7 to the target condition

In addition to improvement in coherence between pre- and post-TMS, differences
were also observed in the subjects’ responses to target and non-target stimuli following
TMS therapy. Analysis of evoked gamma coherence between F4 and T8 to both target
and non-target stimuli indicate that before treatment, non-target coherence was .428 and
target coherence was .451, fairly similar values. However, after completion of TMS
therapy target coherence increased to .559 and non-target coherence decreased to .424.
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The p-value of the comparison of coherence for F4-T8 between target and non-target for
both pre- and post-treatment was .044. These results are illustrated in Figure 32 below.

FIGURE 32 – Comparison of target and non-target evoked gamma coherence (F4-T8)
pre- and post-TMS therapy

Another significant effect of TMS treatment was observed in evoked gamma
coherence between F4 and P4. As in the case above, coherence in response to the target
condition increased significantly following TMS, from .156 to .278. Coherence in
response to the non-target stimuli increased only slightly after the TMS course, from .184
to .211, as seen in Figure 33. The comparison of mean coherence valuesfor F4-P4
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between target and non-target stimuli pre- and post-TMS treatment reached significance
(p = .019).

FIGURE 33 – Comparison of target and non-target evoked gamma coherence (F4-P4)
pre- and post-TMS therapy

Subjects in the waitlist group also completed two Kaniza tasks but did not receive
TMS treatment between the first and second Kanizsa task. Analysis of evoked gamma
coherence between F4 and T8 for those in the waitlist group does not show significant
differences in responses to target and non-target stimuli (p = .724). Similarly, no
significant differences were observed in responses to target and non-target stimuli for
evoked gamma coherence between F4 and P4 (p = .710).
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F. Discussion
Measuring heart rate variability and electrodermal activity is a noninvasive and
effective way to gather information about ANS functioning. Accelerated heart rate in
association with lower HRV index and high electrodermal activity (SCL) found in
children with ASD are indicators of excessive sympathetic and reduced parasympathetic
activation in ASD resulting in a limited psychophysiological flexibility and in behavioral
rigidity. Changes were investigated in autonomic activity during 18 rTMS sessions in
children with ASD. Our hypothesis was that children with ASD would show improved
HRV measures (decreased overall HR, increased RR interval, increased STDHR,
increased SDNN, increased RMSSD, increased pNN50, increased HF and/or decreased
LF, decreased LF/HF ratio), decreased SCL, improved behavioral outcomes, and
increased gamma coherence between long-distance regions of the brain.
Similar data analysis methods were used for the rTMS study as in the prism lens
study. Analysis of HRV began with detection of QRS complexes and producing a series
of successive RR intervals. As in the rTMS study, it was decided that FFT was the
optimal method for spectral analysis of HRV. The only difference in analysis of EEG
coherence was replacing channels C3 and C4 in the montage with channels T7 and T8 to
reflect the emphasis of the Kanizsa task on visual recognition.
Time-domain HRV results show significant increases in both RR interval and
SDNN (standard deviation of the RR interval). The increased RR interval, indicating a
decrease in HR, and the increased standard deviation in RR are promising because they
suggest more prominent parasympathetic activity and more flexibility in heart rate
overall. Within the frequency-domain of HRV, there was increased HF power, which is

53

also very important because this suggests parasympathetic tone was enhanced. As we did
not observe a significant decrease in the LF component, it can be inferred that restoration
of autonomic balance was achieved mainly through increased HF component of HRV,
which correlates to parasympathetic (n. vagus) cardiac neural control. However, while the
change in the LF component was not significant, we did observe a significant decrease in
the LF/HF ratio over 18 sessions of TMS, which shows that some decrease in LF power
did occur. There was also a decrease in SCL over the 18 sessions, which suggests a
withdrawal of sympathetic tone as SCL is controlled solely by sympathetic inputs.
ABC and RBS scores also show that TMS therapy improved behavioral outcomes
of irritability, lethargy, hyperactivity, and stereotypic and compulsive behaviors.
Lastly, gamma coherence analyzed from the Kanizsa task shows that TMS was
effective in improving gamma coherence between frontal and temporal regions, and
between frontal and parietal regions. The increase in frontal-parietal coherence is
especially promising as it has been shown in previous studies that coherence between
long-distance regions is decreased in ASD. In addition to increasing coherence, TMS
therapy also affected the way subjects responded to target versus non-target conditions.
Evoked gamma coherence in response to target stimuli increased significantly post
treatment in both F4-T8 and F4-P4. However, coherence between F4-T8 and F4-P4 in the
waitlist group showed no significant increase in response to the target condition. These
findings indicate that TMS therapy has the potential to improve gamma coherence in
ASD.
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IV. CONCLUSION
Both studies presented in this thesis, prism lens therapy and TMS therapy, were
selected as potential means to improve autonomic balance and gamma coherence in ASD.
Prism lenses address these issues by altering one’s ambient vision and perception of their
surroundings, while TMS works by increasing cortical inhibition. The appropriate
analysis steps were formulated for each type of collected data to transform from the raw
EKG or EEG into a usable RR interval or source waveform, respectively.
Prism lenses proved to be more effective in producing the desired effects on the
autonomic nervous system than on gamma coherence. ASD is thought to adversely affect
ambient vision, thus making it difficult for the individual to interpret his or her
surroundings. The results of this study suggest that wearing prism lenses did in fact help
to improve ambient vision, which may have decreased stress, reflected by the observed
decrease in HR, increase in HF power, decrease in SCL, and improved behavioral
outcomes. Based on these findings, prism lenses show potential for improving autonomic
balance in ASD.
TMS is now being considered for a number of applications, including treatment of
depression (Udupa et al., 2007), improvement of gamma band activity in ASD (Baruth et
al., 2010), and in the case of this study, improvement of autonomic function and gamma
coherence in ASD. The mechanism of low-frequency TMS involves increasing inhibition
of the stimulated cortex. For this study the stimulated region was the DLPFC, which is
linked to ANS control. The findings of the study support the hypothesis that TMS applied
to the DLPFC enhances autonomic balance in ASD through activation of
parasympathetic tone and withdrawal of sympathetic tone. The findings of the TMS study
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also suggest increased gamma coherence as a result of TMS therapy, specifically between
frontal and temporal regions and frontal and parietal regions. Coherence between longdistance regions, such as frontal to parietal, is typically decreased in ASD. These findings
support further investigation into the use of TMS as a means to improve both autonomic
measures and gamma coherence in ASD.
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APPENDIX I: LIST OF ABBREVIATIONS
ABC – Aberrant Behavior Checklist
ADI-R – Autism Diagnostic Interview- Revised
ANS – Autonomic Nervous System
ASD – Autism Spectrum Disorder
DLPFC - Dorsolateral Prefrontal Cortex
DSM-IV – Diagnostic Statistical Manual of Mental Disorders, Fourth Edition
EDA – Elctrodermal Activity
EKG – Electrocardiogram
EMG – Electromyogram
HF – High Frequency component of HRV
HRV – Heart Rate Variability
LF – Low Frequency component of HRV
MT – Motor Threshold
NS.SCR- non-specific Skin Conductance Responses
RBS – Repetitive-Behavior Scale
rTMS – Repetitive Transcranial Magnetic Stimulation
SCL – Skin Conductance Level
SCR – Skin Conductance Response
SPSS – Statistical Package for the Social Sciences
TMS – Transcarnial Magnetic Stimulation
VFL – Very Low Frequency component of HRV
WCEC – Weisskopf Child Evaluation Center
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